Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model-论文-万方医学网

首页> > Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model

Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model

导出原文传递

翻译打印收藏纠错

第一作者： Davis,J.A.

作者： Davis,J.A. ^[1] ; Kumar,P.S. ^[2] ; Singh,S. ^[3] ; Surender,A. ; Roy,S. ; Khanna,V. ; Sethi,S. ; Pal,C. ; Sharma,L. ; Benjamin,B. ; Mittra,S. ; Sattigeri,J. ; Bansal,V.S.

作者单位： Department of Medicinal Chemistry, New Drug Discovery Research, Ranbaxy Research Laboratories ^[1] Department of Metabolism and Pharmacokinetics, New Drug Discovery Research, Ranbaxy Research ^[2] Department of Pharmacology, New Drug Discovery Research, Ranbaxy Research Laboratories, Gurgaon ^[3]

关键词 Antidiabetic effect dipeptidyl peptidase-IV inhibitor glucagon-like peptide-1 oral glucose tolerance test sitagliptin

发布时间 2022-10-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model

相似文献

同项目论文

相关期刊

检索历史 清除

Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model

相似文献

同项目论文

相关期刊

检索历史清除